Nano Vision | Turn the Tide Against Global Health Threats

Join Nano Vision

Dramatically accelerating the development of cures for global health threats.

Request White Paper Join our Telegram

Featured In

View all Press

Updating an Outdated Model

Today, our approach to fighting global health threats is not working. Many dangerous illnesses still lack efficient prevention or treatment options and continue to affect millions of people every day. A single clinical trial can cost between $800 million and $1.4 billion, but 90% of them end in failure. Funding for research initiatives is controlled by governments and institutions and critical data exists in silos around the world, limiting scientific progress. Globally, we spend around $7 trillion each year on healthcare. We’re clearly facing a major imbalance in our system.

90% of Clinical Trials Fail

The Cure for Curing

Breaking Down Barriers

The health challenges we face today are highly complex. To have a real impact, it is critical for all members of the global scientific community to have access to all relevant datasets. We want to usher in a new era of results in global health by removing borders to make important data accessible to all.

More Data Means More Insights

Freeing data from existing silos will create a massive, global pool of data. The more data we have available, the faster we can make life-saving discoveries.

A Community-Driven Marketplace to Accelerate Cures

Using blockchain and a cryptocurrency called Nano Cure™ coin, Nano Vision is creating a simple, elegant solution for today’s stagnated system: a community-driven marketplace that incentivizes data sharing on a global scale.

The Nano Cure™ Platform

Enabling and incentivizing the collection of real-time biological data, creating a dynamic data-sharing marketplace and providing a scalable network of distributed computing power and machine learning, all enabled through the use of our cryptocurrency.

Nano Sense™ Chip

Enabling the real-time stream of molecular data.

Cure Chain ™

Nano's distributed ledger technology.

Inference Engine

AI system to identify trends and draw conclusions.

The Nano Sense™ Chip and Real-Time, Real-World Data

Being developed in partnership with affiliate Nano Global Corporation and Arm, the leading semiconductor IP company, the chip will collect molecular data, a critical subset of biological information in real time, increasing the amount of available data by orders of magnitude.

Nano Cure™ Coin
and Cure Chain™

Contributors to the Nano Vision marketplace will be compensated with Nano Cure™ coins. Nano’s distributed ledger technology, called Cure Chain™, will secure and attribute all data to its correct, original source. This means that if someone contributes data that is used by an institution to develop a critical health solution, they will get credit and and can get compensation for their contribution, just like a musician would receive royalty compensation for the use of his music.

The Inference Engine: Artificial Intelligence & Machine Learning

Forming one of the world's largest datasets, the continuous and massive collection of biological data will enable our artificial intelligence and machine learning systems to act as an inference engine. By identifying trends and drawing conclusions, this inference engine will give the world's brightest minds an entirely new tool to create life-saving solutions.

Initial Health Threat Targets

In partnership with teams at leading research, academic and healthcare institutions, Nano Vision is planning to accelerate the collection and population of key research associated with:

Worldwide infectious diseases

Tuberculosis
Zika
Malaria
Dengue
Chagas

Research and treatments to combat antimicrobial resistance (AMR)

We have several efforts underway including the development of technology and products to avoid perpetrating AMR/Superbugs

Oncology research and treatment for

Pancreatic Cancer
Brain Cancer

Virology research and treatments for

Hepatitis B & C
Influenza A & B
Respiratory syncytial virus

Bacteriology research and treatments for

Hepatitis B & C
Influenza A & B
Respiratory syncytial virus